Benzinga | Jan 24, 2022 01:17PM EST

Analyst Ratings For AbbVie

Within the last quarter, AbbVie (NYSE:ABBV) has observed the following analyst ratings:

Bullish Somewhat Bullish Indifferent Somewhat Bearish BearishTotal Ratings 2 5 3 0 0Last 30D 0 1 0 0 01M Ago 1 1 1 0 02M Ago 0 1 1 0 03M Ago 1 2 1 0 0

According to 10 analyst offering 12-month price targets in the last 3 months, AbbVie has an average price target of $140.9 with a high of $172.00 and a low of $113.00.

Below is a summary of how these 10 analysts rated AbbVie over the past 3 months. The greater the number of bullish ratings, the more positive analysts are on the stock and the greater the number of bearish ratings, the move negative analysts are on the stock

This average price target has increased by 12.33% over the past month.

How Are Analyst Ratings Determined?

Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.

Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.

This article was generated by Benzinga's automated content engine and reviewed by an editor.